Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury. Laskowski J, Renner B, Le Quintrec M, Panzer S, Hannan JP, Ljubanovic D, Ruseva MM, Borza DB, Antonioli AH, Pickering MC, Holers VM, Thurman JM (2016) Kidney Int 90: 109-22 Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Brantley MA, Fang AM, King JM, Tewari A, Kymes SM, Shiels A (2007) Ophthalmology 114: 2168-73 Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Brantley MA, Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A (2007) Am J Ophthalmol 144: 404-408 Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration. Brantley MA, Osborn MP, Sanders BJ, Rezaei KA, Lu P, Li C, Milne GL, Cai J, Sternberg P (2012) Am J Ophthalmol 153: 460-467.e1 Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus. Sardell RJ, Persad PJ, Pan SS, Whitehead P, Adams LD, Laux RA, Fortun JA, Brantley MA, Kovach JL, Schwartz SG, Agarwal A, Haines JL, Scott WK, Pericak-Vance MA (2016) Invest Ophthalmol Vis Sci 57: 6107-6115 Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Borza DB (2017) Matrix Biol 57-58: 299-310 Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA (2009) Br J Ophthalmol 93: 610-3 Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Brantley MA, Edelstein SL, King JM, Plotzke MR, Apte RS, Kymes SM, Shiels A (2009) Eye (Lond) 23: 626-31
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.